Literature DB >> 35180216

Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: Prevision vs. reality of Bangladesh context.

Bilkis Banu1, Nasrin Akter1, Sujana Haque Chowdhury1, Kazi Rakibul Islam1, Md Tanzeerul Islam1, Sarder Mahmud Hossain1.   

Abstract

COVID-19 posed the healthcare professionals at enormous risk during this pandemic era while vaccination was recommended as one of the effective preventive approaches. It was visualized that almost all health workforces would be under vaccination on a priority basis as they are the frontline fighters during this pandemic. This study was designed to explore the reality regarding infection and vaccination status of COVID-19 among healthcare professionals of Bangladesh. It was a web-based cross-sectional survey and conducted among 300 healthcare professionals available in the academic platform of Bangladesh. A multivariate logistic regression model was used for the analytical exploration. Adjusted and Unadjusted Odds Ratio (OR) with 95% confidence intervals (95% CI) were calculated for the specified setting indicators. A Chi-square test was used to observe the association. Ethical issues were maintained according to the guidance of the declaration of Helsinki. Study revealed that 41% of all respondents identified as COVID-19 positive whereas a significant number (18.3%) found as non-vaccinated due to registration issues as 52.70%, misconception regarding vaccination as 29.10%, and health-related issues as 18.20%. Respondents of more than 50 years of age found more significant on having positive infection rather than the younger age groups. Predictors for the non-vaccination guided that male respondents (COR/p = 3.49/0.01), allied health professionals, and respondents from the public organizations (p = 0.01) who were ≤29 (AOR/p = 4.45/0.01) years of age significantly identified as non-vaccinated. As the older female groups were found more infected and a significant number of health care professionals found as non-vaccinated, implementation of specific strategies and policies are needed to ensure the safety precautions and vaccination among such COVID-19 frontiers.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35180216      PMCID: PMC8856526          DOI: 10.1371/journal.pone.0263078

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The reason behind corona virus disease is severe acute respiratory syndrome corona virus 2 (SARS-Cov-2). The disease then spread widely across the globe, causing a severe humanitarian and economic crisis, additionally to the burden on healthcare services. Vaccine hesitancy is one amongst the ten most serious threats to global health. As reported by WHO (2019), reasons behind refusal or unwillingness may be associated with inconvenience in accessing vaccines, complacency, or lack of trust [1]. There’s no other strict way in lieu of vaccinations and it’s the simplest method to regulate rapidly spreading infectious diseases. Waning public confidence in vaccines because of rumors and conspiracy theories may be a major challenge for public health experts and policymakers worldwide [2]. It will be a great strength to make sure the safety of health care workers by the proper implementation of vaccination program for an extended time. To complete vaccination status is incredibly much important for health care professionals under academic platform. These groups of scholars are at higher risk for of contacting and transmitting highly infectious diseases like COVID-19 [3]. Preventive measures face challenges in Bangladesh due to its high population density. Social distancing is difficult in most of the areas of the country, and that’s why mitigation measures are highly challenging. The disease has an alarmingly escalating rate of spread which is significantly higher than many other infectious diseases. It did potentially lead to incapacitate the existing health facilities of the country. Similar scenario happened too even in developed countries with a rapidly increasing Novel coronavirus infection [4]. Health care professionals are usually in greater danger for increased exposure to infectious diseases compared to the common people within the community, and that they may act as vectors for transmission of this virus. Likewise, HCWs in hospital setting are also exposed repeatedly to the disease condition and may induce mutagenicity with development of vulnerable strain [5]. Consequently, this pandemic affected people of all strata within a short period of time particularly the frontline COVID workers on the first hand. Shortage of Doctors and Nurses is another trouble for Bangladesh [6]. A study from African region stated that only 27.7% HCWs would accept vaccine on the basis of availability [7]. COVID-19 posed a significant impact on most crucial sectors of Bangladesh including the economy, agriculture, education, and especially the health sector. As there is fewer data in this issue, our study will explore a new dimension with specific initiatives among the health care professionals in academic platforms. Identifying the present status of Covid-19 vaccination as well as speedy coverage among the health care professionals are further needed in the context of Bangladesh. The outcome of the study will pave suitable guidelines for future extensive research and way-outs for capacity building for full coverage of vaccination among the health care providers. The findings of the study may influence the government to undertake a sustainable program with the aim to stop the spread of the disease and to control the situation.

Methods

Study design

This cross-sectional study was carried out based on retrospective approach and the structured data were collected August 2021 to depict the infection and vaccination status of COVID-19 among healthcare professionals of Bangladesh.

Study participants, sample size and sampling

A total 300 respondents were enrolled in this study who were involved as students of public health department of Northern University Bangladesh (NUB) and also serving as active healthcare professionals in different public and private organizations across the country. Department of public health, NUB has been continuing evening and holiday/weakened based program of Master in Public Health (MPH) since 2006 for the physicians, nurses and allied graduate health professionals i.e. nutritionist, physiotherapist, laboratory technologist, Non-government Organization (NGO) specialist etc. Enrolment in the program are considered as part time academic involvement of the students, who as well as are engaged in their full-time professional work. All enrolled (400) students in summer-2021 semester (May to August 2021) of the MPH program of NUB were considered as participants in this study. Initially it was assumed that a potential standard sample size 384 would be taken by using the formula “n = ‘Z2pq/d2” where Z (standard normal deviate) considered as 1.96; p (proportion of infected and vaccinated healthcare professionals) was unknown and was considered as 0.50 and margin of error was considered as 0.05. However, entirety number of MPH students directed to the declined respondent rate as 335 according to their response to the self-administered data collection instrument. After data cleaning and initial management final sample size was fixed at 300.

Data collection

Data were gathered by self-administered, structured and anonymous online questionnaire. Due to the spread of the COVID-19 pandemic and the lockdown policy enforced within the country, a physical and paper-based questionnaire was not feasible. Thus, respondents were accessed through emails and social media platforms i.e. WhatsApp, and Face book Messenger concurrently. The web link of online survey was ‘https://docs.google.com/forms/d/e/’ which took only 3 to 4 minutes by the respondents to complete. The online web-based survey was administered in English language with the utmost support of the university authority.

Ethical considerations

This study was approved by the Ethical Review Committee of the Department of Public Health of Northern University Bangladesh (NUB/DPH/EC/2021/05-a) and conformed to the Declaration of Helsinki. Participation of the respondents was anonymous and voluntary. Informed consent was sought from the respondents at the beginning of the survey and participants could withdraw from the survey at any time.

Questionnaire design

A Google form was used to develop the online questionnaire. The questionnaire was pre-validated by two independent reviewers and pre-tested among 10 respondents. The responses from the pre-test were used to improve upon the quality of the questionnaire. The questionnaire comprised of several segments: (i) Identification of COVID-19 infection status among the health care professionals; (ii) Reveal of COVID-19 vaccination status including non-vaccination reasons; (iii) Demography of the healthcare professionals: age, gender, geographical location, occupation; (iv) Organizational information: organization type and duration of working experience.

Data analysis

Quality of data was checked and analyzed employing the Statistical Package for the Social Sciences (SPSS) software. Study characteristics were subjected to descriptive statistics (frequency and proportions) to summarize the obtained data. To categorize the data of Age and Experience the cut off value was decided according to previous relevant published articles [8, 9]. A multivariable logistic regression analysis was performed followed by modeling procedure considering backward elimination process, including pre-specified confounders i.e. age, gender, occupation, location, working experience and organization type. Adjusted Odds Ratios with 95% confidence intervals with respect to COVID-19 infection (test positive or test negative) and vaccination status (vaccinated or non-vaccinated) were calculated for the specified exposures.

Results

Participant’s characteristics

A total of 300 respondents were included in this study with 77.7% female and a mean (±SD) age of 38.67 (±9) years. Among the respondents 39.3% (n = 118/300) belonged the age group of 40–49 years. Majority (69.3%, n = 208/300) of the respondents were Nurses and mostly from Dhaka district (65.7%, n = 197). In addition, more than half of the study subjects (57%, n = 171/300) had been serving in the private health care organizations, while 43% had been in government organizations. Moreover, study also revealed that more than half of the subjects (51.3%, n = 154/300) had more than 10 years of professional working experience (Table 1).
Table 1

Characteristics of the respondents according to COVID-19 infection and vaccination status (n = 300).

CharacteristicsCOVID-19 infection statusCOVID-19 vaccination status
Number of participants, n (%)Test Positive, n (%)Test negative, n (%)p-value (≤0.05)Number of participants, n (%)Vaccinated, n (%)Non-vaccinated, n (%)p-value (≤0.05)
Age group (in years)                
    ≤2969 (23.0)19 (6.3)50 (16.7)0.01*69 (23.0)37 (12.3)32 (10.7)0.01*
    30–3978 (26.0)33 (11.0)45 (15.0)78 (26.0)64 (21.3)14 (4.7)
    40–49118 (39.3)49 (16.3)69 (23.0)118 (39.3)114 (38.0)4 (1.3)
    >5035 (11.7)22 (7.3)13 (4.3)35 (11.7)30 (10.0)5 (1.7)
Gender                
     Male67 (22.3)26 (8.7)41 (13.7)0.7767 (22.3)47 (15.7)20 (6.7)0.01*
    Female233 (77.7)97 (32.3)136 (45.3)233 (77.7)198 (66.0)35 (11.7)
Profession                
    Physicians44 (14.7)14 (4.7)30 (10)0.4544 (14.7)32 (10.7)12 (4.0)0.01*
    Nurses208 (69.3)87 (29.0)121 (40.3)208 (69.3)183 (61.0)25 (8.3)
    Allied health professionals48 (16.0)22 (7.3)26 (8.7)48 (16.0)30 (10.0)18 (6.0)
Experience                
    ≤10146 (48.7)51 (17.0)95 (31.7)0.04*146 (48.7)106 (35.3)40 (13.3)0.01*
    >10154 (51.3)72 (24.0)82 (27.3)154 (51.3)139 (46.3)15 (5.0)
Type of Organization                
    Private171 (57.0)74 (24.7)97 (32.3)0.45171 (57.0)148 (49.3)23 (7.7)0.01*
    Public129 (43.0)49 (16.3)80 (26.7)129 (43.0)97 (32.3)32 (10.7)
Geographic Location                
    Dhaka197 (65.7)84 (28.0)113 (37.7)0.57197 (65.7)163 (54.3)34 (11.3)0.01*
    Barisal24 (8.0)11 (3.7)13 (4.3)24 (8.0)23 (7.7)1 (0.3)
    Chittagong46 (15.3)17 (5.7)29 (9.7)46 (15.3)29 (9.7)17 (5.7)
    Khulna15 (5.0)3 (1.0)12 (4.0)15 (5.0)15 (5.0)0 (0.0)
    Raj Shahi8 (2.7)3 (1.0)5 (1.7) 8 (2.7)8 (2.7)0 (0.0)
    Mymensingh10 (3.3)5 (1.7)5 (1.7) 10 (3.3)7 (2.3)3 (1.0)

Data are presented as frequency (n), percentage (%)

*Statistical significance at p value ≤0.05. Chi-square test was used to observe the association.

Data are presented as frequency (n), percentage (%) *Statistical significance at p value ≤0.05. Chi-square test was used to observe the association.

COVID-19 infection status among the health professionals

Among the health care professionals, nearly half (41%, n = 123/300) were revealed as COVID-19 test positive whereas 59% were found negative (Fig 1).
Fig 1

This is the status of COVID-19 infection among the respondents (n = 300).

COVID-19 vaccination status among the health professionals

Most of the health care professionals (81.7%, n = 245/300) were found as vaccinated where a good number (18.3%, n = 55/300) did not take any vaccine (Fig 2). The reasons for not being vaccinated were Registration issues (52.70%), Misconception (29.10%) and Health related issues (18.20%) (Fig 2).
Fig 2

This is the status of COVID-19 vaccination including reasons for non-vaccination among the respondents (n = 300).

Respondent’s characteristics associated with the COVID-19 infection and vaccination status

Results of multivariate (cross table) analysis revealed that respondents’ age (p = 0.01) and professional working experience (p = 0.04) is significantly associated with the COVID-19 infection status. On the other hand, vaccination status among the respondents significantly influenced by the demographic characteristics like age, gender, profession, working experience, types of organization and geographic location (p = 0.01). Study also revealed that comparatively more COVID-19 infection found among the female who were nurse as their occupation whereas the group of allied health professionals found as the second largest group infected with COVID-19. In addition, COVID-19 infection predominantly found among the health care professionals who were from the Dhaka district. Furthermore, COVID-19 vaccination status revealed that 40–49 years age group and female subjects who were in nursing profession found more vaccinated, compared to others. HCWs who had more than 10 years of experience and from private organizations of Dhaka city were found more vaccinated than others (Table 1).

Predictors regarding COVID-19 infection and vaccination status among the respondents

Multivariable logistic regression analysis was done to identify the predictors. A backward step-by-step binary logistic regression (simple and multiple) was performed after the placement of all the significant predictors (p<0.05) in final model. It was revealed from the adjusted model that respondents aged more than 50 years were more COVID positive rather than the younger age groups (≤29 years, COR/p = 0.23/0.01, AOR = 0.22/0.01; 30–39 years, COR/p = 0.43/0.04 & AOR/p = 0.43/0.04; 40–49 years, COR/p = 0.42/0.03 & AOR/p = 0.42/0.03). On the other hand, predictors regarding COVID-19 vaccination status revealed that respondents who were ≤29 (AOR/p = 4.45/0.01) and >50 years of age found significantly reluctant to be vaccinated. In addition, male (COR/p = 3.49/0.01) respondents, allied health professionals and respondents from the public organizations were (p = 0.01) significantly identified as non-vaccinated compared to corresponding groups (Table 2).
Table 2

Identified predictors associated with the COVID-19 infection and vaccination status (n = 300).

CharacteristicsCOVID-19 infection statusCOVID-19 vaccination status
Test negative vs test positive counterNon-Vaccinated vs vaccinated counter
Un-adjusted OR (95% CI)p-valueAdjusted OR (95% CI)p-valueUn-adjusted OR (95% CI)p-valueAdjusted OR (95% CI)p-value
Age group (in years)   
    ≤290.23 (0.09–0.53)0.01*0.22 (0.09–0.53)0.01*5.19 (1.80–14.95)0.01*4.45 (1.51–13.08)0.01*
    30–390.43 (0.19–0.98)0.04*0.43 (0.19–0.98)0.04*1.31 (0.43–3.98)0.631.09 (0.35–3.39)0.88
    40–490.42 (0.19–0.91)0.03*0.42 (0.19–0.91)0.03*0.21 (0.05–0.83)0.03*0.22 (0.06–0.89)0.03*
    >50ReferenceReference
Gender   
    Male0.89 (0.51–1.55)0.682.41 (1.28–4.54)0.01*
    FemaleReferenceReference
Profession   
    Physicians0.55 (0.24–1.29)0.170.63 (0.26–1.51)0.290.56 (0.21–1.47)0.24
    Nurses0.85 (0.46–1.59)0.610.23 (0.11–0.47)0.01*0.34 (0.15–0.76)0.01*
    Allied health professionalsReferenceReference
Experience   
    ≤100.61 (0.38–0.97)0.04*3.49 (1.84–6.67)0.01*
    >10ReferenceReference
Type of Organization   
    Private1.25 (0.78–1.99)0.360.47 (0.26–0.85)0.01*
    PublicReferenceReference
Geographic Location   
    Dhaka0.74 (0.21–2.65)0.650.03*0.49 (0.12–1.98)0.31
    Barisal0.85 (0.19–3.71)0.830.080.10 (0.01–1.14)0.06
    Chittagong0.59 (0.15–2.32)0.450.04*1.36 (0.31–6.01)0.68
    Khulna0.13 (0.04–1.47)0.13
    Raj Shahi0.59 (0.09–3.98)0.59
    MymensinghReferenceReference

Logistic Regression Analysis was used to identify the predictors

* Statistical significance at p value ≤0.05.

Logistic Regression Analysis was used to identify the predictors * Statistical significance at p value ≤0.05.

Discussions

Availability and efficacy of the COVID-19 vaccine are vivacious for a successfully control of pandemic. Our study identifies COVID-19 status and vaccination and its predictor for non-vaccination status of among health workers in Bangladesh. Majority of the participants were nurses (69.3%) followed by Allied health professionals (16%), and physicians (14.7%). Highlighting upon the test result of COVID-19 41% reported positive test result among total respondents, while another cohort study in New Jersey, USA reported that only 5.0% of all health care providers were tested positive in university hospital among whom majority (62.5%) were nurses and the positive tests increased across the two weeks of cohort recruitment. To minimize the prevalence they recommended continuous follow-up, monitoring infection rates and examine risk factors for transmission as the possible way outs need to come in action [10]. Compare to that scenario, as infection rate is much higher in Bangladesh, it is pivotal issue for the rapid surveillance. In addition, monitoring and screening system of COVID-19 infection with risk factor identification needs to be emphasized among the health care providers of the country. Moving upon vaccination status it was observed that 81.7% were found as vaccinated where a significant amount 18.3% were non-vaccinated. However, it was expected that as frontiers vaccination program will cover all the health care professionals as priority according to the registration guideline of vaccination in Bangladesh [11]. As the scientific evidence regarding vaccination status among health care providers is not available in the intellectual platform, the outcome of this study might give a new outlook for the health wellbeing of this vital group in our community. From nurses’ group highest (87.9%) number of participants reported a complete vaccination status compare to physician group, whereas lowest (10%) was reported from alight group of respondents. There are a very few studies available indicating the COVID-19 status and vaccination among healthcare professionals as frontline workers in Bangladesh. While identifying the reasons for not being vaccinated, it was found that “registration issues” like waiting for confirmation massage was reported highest (52.70%) and list (18.20%) reported fact was having health issues like pregnancy. Furthermore, misconception regarding vaccination was observed among (29.1%) healthcare workers (HCWs). This study findings coincide with another study in Bangladesh says that HCWs think the vaccine might not be safe or effective due to emergency authorization [12]. Similar in a study from Ghana, finding was observed that healthcare workers in Ghana got misconception regarding safety and adverse side effects of the vaccines, which identified as main reasons why health care workers would decline uptake of COVID-19 vaccines [13]. Association between socio demographic factors and COVID status, it was found that age and working experience of respondents had a positive relation. Respondent having working experience more than 10 years reported highest (51.3%) positive test result of COVID-19. Having good management skill with increased workload or less availability of PPE may act as driving impetus behind more positive test result and handling more COVID patient. Furthermore, age group between 40–49 years reported maximum infectivity history compare to other age group, whereas age group less than 29 reported minimum (23%) infectivity history. This result part agrees with a study in Bangladesh reveal that HCWs whose age is under 20 years are more likely to not be infected by COVID-19 than those above that age group [14]. Highlighting upon the association between vaccination status and socio demographic factors, every factor like age, gender, profession, experience, organization type found to have significant association with vaccination. In this study female, nurses in age group 40–49, serving in a private organization with a working experience >10 reported complete vaccination status. This study finding unfortunately contradict with a study finding says that female found to be a contributing factor to the low vaccine acceptance rate in Egypt [15]. Concerning upon the predictor respondents aged more than 50 years found significantly reporting of having positive infection history rather than the younger age groups. Mostly similar to this finding coincide to a study identifying highest infection and deaths reported among HCWs aged over 70 years per 100 infections [16]. Predictors concerning age related to COVID-19 vaccination status it was found that respondents age group ≤29 identified as significant predictor for non-vaccination. Extreme age group with undiversified working experience and knowledge may act as main reason for this reluctance. Very few studies found supporting this study result. In addition, male respondents were more likely to be non-vaccinated. This study finding contradict with many of article, which says that female respondents were more reluctant toward the vaccine where safety and efficacy concerns of vaccine were the significant predictors of vaccine hesitancy [17]. Allied health professionals and respondents from the public organizations were found to be significant predictor for non-vaccinated in this pandemic. Prolong registration procedure or working hour may work behind this phenomenon. Although our students representing a large number of health care professionals throughout Bangladesh but we could not develop the sampling frame from all the health care facilities or organizations from the whole country due to lack of resources, funding and time constrains. Therefore, we did this formative study visualizing the initial situation of vaccination status and the associated risk factors among the health care professionals in Bangladesh. The unique outcome of this study is the strength of the preventive approach of COVID-19 infection among the health care professionals which might be the mounting for further scientific initiatives. Thus, the further large-scale survey is needed to generalize the conclusion as well as planning for the specific intervention in priority basis.

Conclusions

A significant diversity was found in this study concerning Covid infection and vaccination status among different categories of health professionals in the academic settings. Nearly half of respondents had COVID-19 positive infection whereas 18.3% of respondents were found as non-vaccinated. It was an alarming health issue in a serious ongoing pandemic situation like novel corona virus infection. Although the female nurses’ group was more infected as a front-line healthcare provider in spite of their higher vaccination status. Less response on vaccination was found among the allied and younger age group health professionals. The caregiver with less professional experience (<10 years) were found as more positive and non-vaccinated. Registration issues and misconceptions about vaccines were branded as first and second most leading cause behind the non-vaccination status. Thus, clarity-based scrutinization is required on infection control measures for such front-line health workers. Proper approaches are needed to ensure a successful vaccination program among the health professionals to inspire a voluntary successful vaccination. Health awareness programs highlighting the benefits of vaccination through behavior change communication are needed to aware such populations to ensure a safer workplace. (DOCX) Click here for additional data file. (SAV) Click here for additional data file. (CSV) Click here for additional data file. 5 Nov 2021
PONE-D-21-30587
Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: prevision vs. reality of Bangladesh context
PLOS ONE Dear Dr. Akter, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Khin Thet Wai, MBBS, MPH, MA Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. PLOS ONE does not copy edit accepted manuscripts (https://journals.plos.org/plosone/s/criteria-for-publication#loc-5). To that effect, please ensure that your submission is free of typos and grammatical errors. *Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. Thank you for stating the following financial disclosure: [No funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files. Additional Editor Comments: This is the important manuscript that requires an improvement. 1. Authors need to modify the data analysis, interpretation of results and to strengthen the discussion section. 2. There are grammatical errors throughout and English language editing is deemed necessary. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study is interesting and important study for Bangladesh in fighting against COVID-19 outbreak. But, the manuscript still needs to improve the data analysis, presentation of the findings and implication of the study. Background - Need to describe the justification of the study clearly - Study design with retrospective and structure: What does it mean? - What is your study setting? Which responsibility did your participants take in which region? Are they still students or already graduated? - In data analysis, need to describe how did you consider your final multivariable logistic model for each outcome variable - When I check in the table 2, there are only 1 or 2 variables for AOR? Is it final model? Please explain. Result session: - In my opinion, 41% is not nearly half. - Fig 1 and 2 should be pie chart. Figure 1 and 2 can be only one figure saying Fig 1.1 and 1.2. Fig 3 can also be combined to figure 2. Vaccination status and reasons for not having vaccines - In my opinion, Table 1 and 2 should not be supplementary tables. Should describe as main table. - Description of the results should be in text. Should not under the figure as picture. - Regarding the result of preditors, I would like to suggest to describe the results from multivariable logistic regression with AOR. - Did you add vaccine status as one of the predictor for COVID-19 infection? Discussion - Please discuss about 41% has infected. Please compare with other studies and what is the implication of your study? How will you apply? - Please discuss about 81.7% has infected. Please compare with other studies and what is the implication of your study? How will you apply? - Please describe the strength and limitation of your study. - Please clearly describe the implication from your study. - Please mention how you can make generalizability from your study population and sample size. Can we conclude this study represents all the health professional? Reviewer #2: overall the manuscript technically good and data analysis ok and overall well written except few grammatic errors reasonably current pandaemic this paper will open up most of the countries still campaigning for vaccination ok for acceptance ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Thae Maung Maung Reviewer #2: Yes: Kandamaran Krishnamurthy [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. Submitted filename: Reviewer Comment_Plos One.docx Click here for additional data file. Submitted filename: Table file_Reviewer.docx Click here for additional data file. 6 Dec 2021 Reviewer's Comment Response Background 1. Need to describe the justification of the study clearly Modified in line 71-86 2. Study design with retrospective and structure: What does it mean? Modified in line 91-92 3. What is your study setting? Which responsibility did your participants take in which region? Are they still students or already graduated? Already Mentioned in line 95-96 and 100-101 4. In data analysis, need to describe how did you consider your final multivariable logistic model for each outcome variable Modified in line 133-134 5. When I check in the table 2, there are only 1 or 2 variables for AOR? Is its final model? Please explain. Yes, it is the final model. We did the final model by backward elimination of the study variables. Result 1. In my opinion, 41% is not nearly half. Modified in line 149-50 2. Fig 1 and 2 should be pie chart. Figure 1 and 2 can be only one figure saying Fig 1.1 and 1.2. Fig 3 can also be combined to figure 2. Vaccination status and reasons for not having vaccines. Modified as fig 1 and fig 2. We have merged fig 2 & 3 into new fig 2. 3. In my opinion, Table 1 and 2 should not be supplementary tables. Should describe as main table. Added in the result section 4. Description of the results should be in text. Should not under the figure as picture. Modified the figures 5. Regarding the result of predators, I would like to suggest to describe the results from multivariable logistic regression with AOR. Already mentioned in result section in line 180-186 6. Did you add vaccine status as one of the predictors for COVID-19 infection? No, we did not find any association between vaccination status and infection status. Discussion 1. Please discuss about 41% has infected. Please compare with other studies and what is the implication of your study? How will you apply? Modified in lines 197-206 2. Please discuss about 81.7% has infected. Please compare with other studies and what is the implication of your study? How will you apply? Modified in lines 207-219 3. Please describe the strength and limitation of your study. Added in lines 257-265 4. Please clearly describe the implication from your study. 5. Please mention how you can make generalizability from your study population and sample size. Can we conclude this study represents all the health professional? Editor's Comment Authors need to modify the data analysis, interpretation of results and to strengthen the discussion section. Addressed in the track changed manuscript file There are grammatical errors throughout and English language editing is deemed necessary. Corrected and modified Submitted filename: Response to reviewer.docx Click here for additional data file. 5 Jan 2022
PONE-D-21-30587R1
Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: prevision vs. reality of Bangladesh context
PLOS ONE Dear Dr. Akter, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
Please submit your revised manuscript by Feb 19 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Khin Thet Wai, MBBS, MPH, MA Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): Minor grammatical errors throughout the manuscript require correction. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Reviewer’s comments_R1 - What does it mean “retrospective approach” in line 83-84. This cross-sectional study was carried out based on retrospective approach and the structured data were collected - Need to mention more detail about the student participants to get clear presentation for readers. Not enough described in line 95-96 and 100-101. - What is the total number of students in in summer-2021 semester (May to August 2021) of the MPH program of NUB? Are public health students are part-time students? Are they also working? - The sample size said 384 but the study enrolled 300 students? What is your explanation for that? - In data analysis, AOR should be used in stead of OR in multivariable logistic regression. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Yes [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
Submitted filename: Reviewer Comments_R1.docx Click here for additional data file. 11 Jan 2022 Reviewer's Comment 1. What does it mean “retrospective approach” in line 83-84. Response: As the data was collected based on past history of their COVOD-19 infection and vaccination as we mentioned in the method. 2. Need to mention more detail about the student participants to get clear presentation for readers. Not enough described in line 95-96 and 100-101. Response: Already Mentioned in line 95-96 and 100-101 3. What is the total number of students in in summer-2021 semester (May to August 2021) of the MPH program of NUB? Are public health students being part-time students? Are they also working? Response: Modified in line 91-95 4. The sample size said 384 but the study enrolled 300 students? What is your explanation for that? Response: Already Mentioned in line 101-103 5. In data analysis, AOR should be used instead of OR in multivariable logistic regression. Response: Modified in line 133 Editor's Comment Minor grammatical errors throughout the manuscript require correction. Response: Already addressed Submitted filename: Response to reviewer.docx Click here for additional data file. 12 Jan 2022 Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: prevision vs. reality of Bangladesh context PONE-D-21-30587R2 Dear Dr. Akter, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Khin Thet Wai, MBBS, MPH, MA Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 8 Feb 2022 PONE-D-21-30587R2 Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: prevision vs. reality of Bangladesh context Dear Dr. Akter: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Khin Thet Wai Academic Editor PLOS ONE
  12 in total

1.  Vaccination against COVID-19 in Bangladesh: Perception and Attitude of Healthcare Workers in COVID-dedicated Hospitals.

Authors:  M Nasir; R A Perveen; S K Saha; A Nessa; A Zaman; R Nazneen; J Ferdous; N Farha; T K Majumder; M J Hossain; S Parvin; M R Chowdhury; H Begum; F Ahmed
Journal:  Mymensingh Med J       Date:  2021-07

2.  COVID-19 Vaccination Intent and Willingness to Pay in Bangladesh: A Cross-Sectional Study.

Authors:  Russell Kabir; Ilias Mahmud; Mohammad Tawfique Hossain Chowdhury; Divya Vinnakota; Shah Saif Jahan; Nazeeba Siddika; Samia Naz Isha; Sujan Kanti Nath; Ehsanul Hoque Apu
Journal:  Vaccines (Basel)       Date:  2021-04-21

3.  Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study.

Authors:  Muhammed Elhadi; Ahmed Alsoufi; Abdulmueti Alhadi; Amel Hmeida; Entisar Alshareea; Mawadda Dokali; Sanabel Abodabos; Omaymah Alsadiq; Mohammed Abdelkabir; Aimen Ashini; Abdulhamid Shaban; Saja Mohammed; Nehal Alghudban; Eman Bureziza; Qasi Najah; Khawla Abdulrahman; Nora Mshareb; Khawla Derwish; Najwa Shnfier; Rayan Burkan; Marwa Al-Azomi; Ayman Hamdan; Khadeejah Algathafi; Eman Abdulwahed; Khadeejah Alheerish; Naeimah Lindi; Mohamed Anaiba; Abobaker Elbarouni; Monther Alsharif; Kamal Alhaddad; Enas Alwhishi; Muad Aboughuffah; Wesal Aljadidi; Aisha Jaafari; Ala Khaled; Ahmed Zaid; Ahmed Msherghi
Journal:  BMC Public Health       Date:  2021-05-20       Impact factor: 3.295

4.  COVID-19 and Bangladesh: Challenges and How to Address Them.

Authors:  Saeed Anwar; Mohammad Nasrullah; Mohammad Jakir Hosen
Journal:  Front Public Health       Date:  2020-04-30

5.  Pertussis vaccination status and vaccine acceptance among medical students: multicenter study in Germany and Hungary.

Authors:  Mandy Böhme; Karen Voigt; Erika Balogh; Antje Bergmann; Ferenc Horváth; Joachim Kugler; Jörg Schelling; Jeannine Schübel; Henna Riemenschneider
Journal:  BMC Public Health       Date:  2019-02-12       Impact factor: 3.295

6.  Comparison of COVID-19 infections among healthcare workers and non-healthcare workers.

Authors:  Rachel Kim; Sharon Nachman; Rafael Fernandes; Kristen Meyers; Maria Taylor; Debra LeBlanc; Adam J Singer
Journal:  PLoS One       Date:  2020-12-09       Impact factor: 3.240

7.  Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review.

Authors:  Soham Bandyopadhyay; Ronnie E Baticulon; Murtaza Kadhum; Muath Alser; Daniel K Ojuka; Yara Badereddin; Archith Kamath; Sai Arathi Parepalli; Grace Brown; Sara Iharchane; Sofia Gandino; Zara Markovic-Obiago; Samuel Scott; Emery Manirambona; Asif Machhada; Aditi Aggarwal; Lydia Benazaize; Mina Ibrahim; David Kim; Isabel Tol; Elliott H Taylor; Alexandra Knighton; Dorothy Bbaale; Duha Jasim; Heba Alghoul; Henna Reddy; Hibatullah Abuelgasim; Kirandeep Saini; Alicia Sigler; Leenah Abuelgasim; Mario Moran-Romero; Mary Kumarendran; Najlaa Abu Jamie; Omaima Ali; Raghav Sudarshan; Riley Dean; Rumi Kissyova; Sonam Kelzang; Sophie Roche; Tazin Ahsan; Yethrib Mohamed; Andile Maqhawe Dube; Grace Paida Gwini; Rashidah Gwokyala; Robin Brown; Mohammad Rabiul Karim Khan Papon; Zoe Li; Salvador Sun Ruzats; Somy Charuvila; Noel Peter; Khalil Khalidy; Nkosikhona Moyo; Osaid Alser; Arielis Solano; Eduardo Robles-Perez; Aiman Tariq; Mariam Gaddah; Spyros Kolovos; Faith C Muchemwa; Abdullah Saleh; Amanda Gosman; Rafael Pinedo-Villanueva; Anant Jani; Roba Khundkar
Journal:  BMJ Glob Health       Date:  2020-12

8.  Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic.

Authors:  Emily S Barrett; Daniel B Horton; Jason Roy; Maria Laura Gennaro; Andrew Brooks; Jay Tischfield; Patricia Greenberg; Tracy Andrews; Sugeet Jagpal; Nancy Reilly; Jeffrey L Carson; Martin J Blaser; Reynold A Panettieri
Journal:  BMC Infect Dis       Date:  2020-11-16       Impact factor: 3.090

9.  Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study.

Authors:  Rehab H El-Sokkary; Omnia S El Seifi; Hebatallah M Hassan; Eman M Mortada; Maiada K Hashem; Mohamed Rabie Mohamed Ali Gadelrab; Rehab M Elsaid Tash
Journal:  BMC Infect Dis       Date:  2021-08-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.